首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1347197

2030 年地中海魚類疫苗市場預測 - 按疫苗類型、給藥途徑、物種和國家進行區域分析

Mediterranean Fish Vaccine Market Forecast to 2030 - Regional Analysis by Vaccine Type, Route of Administration, Species, and Country

出版日期: 2023年08月10日 | 出版商:

The Insight Partners | 英文 199 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

地中海魚苗市場規模預計將從2022年的963.2346億美元增至2030年的2090.308億美元；預計2022年至2030年年複合成長率為10.2%。

消費者越來越意識到動物蛋白的營養價值。對更少或不含藥物的健康、永續、高品質肉製品的需求也在迅速成長。對水生動物食品（油、魚子醬、蛋白粉、肉類等）的需求不斷成長，鼓勵農民接種疫苗以保障水產養殖並獲得高利潤。

作為健康飲食的一部分，經常食用魚類被廣泛提倡。與陸生動物肉相比，魚類的蛋白質含量較高，這一點通過飼料轉化率 (FCR) 低於陸生動物即可看出。此外，魚蛋白易消化且富含必需氨基酸，這與必需氨基酸含量較低的動物源蛋白不同。通過不同的研究，食用魚類和貝類與降低心臟病、炎症和關節炎的風險有關。魚的健康益處主要與長鏈 omega 3 (n-3) 多不飽和脂肪酸 (PUFA) 的存在有關。此外，魚蛋白富含生物活性肽，如果以適當的濃度食用以支持其在人體內的最佳生物利用度，則可以提供許多健康益處。食用魚類的其他健康益處包括通過抑制腎素-血管緊張素-醛固酮系統（RAAS）內的酶來控制血壓；維持骨骼健康；控制炎症（抗氧化肽）；通過鴉片肽和血小板激活因子乙醯水解酶（PAF-AH）抑制肽的作用維持心理健康；等等。因此，水生動物源性蛋白質對健康的巨大益處表明需要對這些動物進行健康飼養，從而推動了地中海地區對魚類疫苗的需求。

新型疫苗的開發：地中海魚疫苗市場的機遇

由細菌、病毒和寄生蟲引起的各種疾病的爆發已經減緩了全球水產養殖業的發展數十年。除了危害人類健康外，新出現的疾病也極大地影響水生動物。疫苗接種是一種眾所周知的、有效的預防措施，用於解決這個問題。然而，傳統疫苗仍然存在一些缺點和局限性，這促使研究人員將注意力轉向嵌合多表位疫苗等新型疫苗。基於目前對基因組學和免疫蛋白質組學的理解以及目前可用的生物資訊學工具，研究人員現在可以識別免疫細胞識別的潛在目標表位。此外，隨著全基因組測序等技術的成本持續下降，它為物種特異性疫苗的開發開闢了道路。這些因素可能會鼓勵地中海魚類疫苗市場參與者投資開發針對目前尚無疫苗的病毒、寄生蟲或細菌傳染病的新疫苗。

此外，有效粘膜疫苗的開發及其管理流程的最佳化預計將加速新型疫苗的開發，進而鼓勵地中海國家的水產養殖企業規範魚類疫苗接種流程。緊急（自體）疫苗的有效使用預計將有助於應對新出現的疾病挑戰，並為市場參與者創造巨大的發展機會。

地中海魚類疫苗市場分為疫苗類型、物種、給藥途徑、臨床適應症和國家。根據疫苗類型，市場分為去活化疫苗、減毒活疫苗、類毒素疫苗、亞單位疫苗、結合疫苗和重組載體疫苗。根據物種，地中海魚類疫苗市場分為大菱鮃、歐洲鳀魚和鱸魚、鮭魚、地中海鱸魚、普通齒魚和普通潘多拉魚、鯛魚、虹鱒、黑鯛、鱒魚、地中海箭魚和藍鰭金槍魚、石斑魚和琥珀魚等。從給藥途徑來看，市場分為浸沒疫苗、注射疫苗和口服疫苗。並根據臨床適應症，市場分為細菌感染和病毒感染。根據地區，對法國、義大利、西班牙、埃及、希臘、土耳其、以色列和地中海其他地區的市場進行了分析。該地區市場的成長是由蓬勃發展的水產養殖業和加強疫苗研發的舉措推動的。土耳其在世界上最大的海水魚類養殖國中排名第九，其水產養殖產量在所有歐洲國家中名列前茅。水產養殖佔土耳其海鮮年產量的 44.6% 左右。該國聲稱擁有世界上成長最快的食品生產工業。土耳其擁有 434 個正在營運的海水養殖設施，生產金頭鯛和歐洲鱸魚。過去二十年，技術進步促進了鱸魚和鯛魚產量的快速成長。因此，該國已成為世界上最大的鯛魚和鱸魚生產國，滿足全球約 40% 的需求。此外，由於政府努力將魚類推廣為低碳足跡的健康產品，該國的魚類消費量正在上升。根據土耳其海洋研究基金會 (TUDAV) 2021 年 1 月發布的估計，到 2023 年，該國的魚類產量將達到 60 萬噸，出口額為 170 萬美元（160 萬歐元）。

另一方面，管理水產養殖和養魚場的各種疾病是土耳其水產養殖企業面臨的主要挑戰。這一挑戰可以通過定期魚類疫苗接種來應對。因此，土耳其大規模的魚類生產可能會擴大未來幾年對魚類疫苗的需求。

聯合國糧食及農業組織 (FAO)、經濟合作與發展組織 (OECD)、歐盟、土耳其海洋研究基金會 (TUDAV) 是編寫報告時提到的幾個關鍵的主要和次要來源地中海魚類疫苗市場。

Consumers are becoming aware of the nutritious value of animal protein. The demand for healthy, sustainable, high-quality meat products with fewer or no drugs is also increasing rapidly. The growing demand for food products derived from aquatic animals (oil, caviar, protein powders, meat, etc.) encourages farmers to undertake vaccinations to safeguard aquaculture and attain high profitability.

Regular fish consumption is widely promoted as a part of a healthy diet. Fishes have a high protein content compared to terrestrial animal meat, which is evident through lower feed conversion rates (FCR) than land animals. Moreover, fish proteins are highly digestible and rich in essential amino acids, unlike animal-sourced proteins that have low essential amino acid content. Fish and shellfish consumption has been associated with a decreased risk of heart disease, inflammation, and arthritis through different research studies. The health benefits of fish are mainly linked to the presence of long-chain omega 3 (n-3) polyunsaturated fatty acids (PUFA). In addition, fish proteins are enriched with bioactive peptides, which offer many health benefits if consumed in appropriate concentrations that support their optimal bioavailability within the human body. Other health benefits of fish consumption include the control of blood pressure through the inhibition of enzymes within the renin-angiotensin-aldosterone system (RAAS); maintenance of bone health; control of inflammation (antioxidant peptides); and maintenance of mental health through the action of opioid peptides and platelet-activating factor acetyl-hydrolase (PAF-AH) inhibitory peptides; and so on. Thus, the tremendous health benefits of aquatic animal-derived proteins indicate the need for healthy breeding of these animals, which propels the demand for fish vaccines in the Mediterranean region.

Development of Novel Vaccines: Opportunity for the Mediterranean Fish Vaccine Market

Various disease outbreaks caused by bacteria, viruses, and parasites have decelerated the progress of the global aquaculture industry for several decades. Besides harming human health, emerging diseases also dramatically affect aquatic animals. Vaccination is a well-known, effective prophylactic measure employed to manage this problem. However, traditional vaccines still have several drawbacks and limitations, which has driven the focus of researchers to novel vaccines such as chimeric multiepitope vaccines. Based on the current understanding of genomics and immunoproteomics, and the presently available bioinformatics tools, researchers can now identify the potential targeted epitopes that are recognized by immune cells. Further, Fish Species with a as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. These factors are likely to encourage the Mediterranean fish vaccine market players to invest in developing new vaccines against viral, parasitic, or bacterial infectious diseases for which vaccines are presently unavailable.

Further, the development of effective mucosal vaccines and optimization of their administration process are expected to accelerate novel vaccine development, in turn, encouraging aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. The effective use of emergency (autogenous) vaccines is anticipated to help handle emerging disease challenges and create immense opportunities for the market players to grow.

The Mediterranean fish vaccine market is segments into vaccine type, species, route of administration, clinical indication, and country. Based on the vaccine type, the market is bifurcated into inactivated vaccine, live-attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and recombinant vector vaccine. Based on species, the Mediterranean fish vaccine market is bifurcated into turbot, European anchovy and seabass, salmon, Mediterranean sea bass, common dentex and common pandora, sea bream, rainbow wrasse, Sparus aurata, trout, Mediterranean swordfish and bluefin tuna, grouper and amberjack, and others. In terms of route of administration, the market is segmented into immersion vaccine, injection vaccine, and oral vaccine. And based on clinical indication, the market is classified as bacterial infection and viral infection. Based on the region, the market is analyzed on the basis of France, Italy, Spain, Egypt, Greece, Turkey, Israel, and the Rest of the Mediterranean. The growth of the market in this region is driven by the flourishing aquaculture industry and increasing initiatives to enhance research and development of vaccines. Turkey ranks ninth among the largest marine fish farming countries in the world, and it records significant aquaculture production among all European countries. Aquaculture accounts for ~44.6% of the total annual seafood production in Turkey. The country claims to have the fastest-growing food production industry in the world. Turkey has 434 operational marine aquaculture facilities, producing gilthead seabream and European seabass. Technological advancements have facilitated the rapid growth in sea bass and sea bream production in the past two decades. Thus, the country has become the world's top producer of sea bream and sea bass, meeting ~40% of the global demand. Moreover, fish consumption in the country is rising due to the government's efforts to promote fish as a healthy product with a low carbon footprint. According to the Turkish Marine Research Foundation (TUDAV) estimates published in January 2021, the country's fish production would reach 600,000 tons by 2023, accounting for exports of US$ 1.7 million (€1.6 million).

On the other hand, managing various diseases in aquaculture and fish farms is a major challenge faced by Turkish aquaculture businesses. This challenge is handled by regular fish vaccination. Thus, the large scale of fish production in Turkey is likely to expand the demand for fish vaccines in the coming years.

The Food and Agriculture Organization of the United Nations (FAO), the Organisation for Economic Co-operation and Development (OECD), European Union, Turkish Marine Research Foundation (TUDAV) are a few key primary and secondary sources referred to while preparing the report on the Mediterranean fish vaccine market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Mediterranean fish vaccine market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global Mediterranean fish vaccine market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global Mediterranean fish vaccine market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Mediterranean Fish Vaccine Market - Market Landscape

4.1 Overview
- 4.1.1 Mediterranean Region PEST Analysis
4.2 Mediterranean Fish Species
4.3 List of Mediterranean Fish Species

5. Mediterranean Fish Vaccine Market - Regional Analysis

5.1 Key Market Drivers:
- 5.1.1 Government Initiatives to Develop Mediterranean Aquaculture Industry
- 5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
5.2 Key Market Restraints:
- 5.2.1 Strict Regulatory Policies for Approval of Vaccines
5.3 Key Market Opportunities:
- 5.3.1 Development of Novel Vaccines
5.4 Future Trends:
- 5.4.1 Shift from Conventional Vaccines to DNA Vaccines
5.5 Impact Analysis:

6. Mediterranean Fish Vaccine Market - Regional Analysis

6.1 Mediterranean Fish Vaccine Market Revenue Forecast and Analysis

7. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

7.1 Overview
7.2 Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
7.3 Inactivated Vaccine
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Live Attenuated Vaccine
- 7.4.1 Overview
- 7.4.2 Live Attenuated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Toxoid Vaccine
- 7.5.1 Overview
- 7.5.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Subunit Vaccine
- 7.6.1 Overview
- 7.6.2 Subunit Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Conjugate Vaccine
- 7.7.1 Overview
- 7.7.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Recombinant Vector Vaccine
- 7.8.1 Overview
- 7.8.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

8. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

8.1 Overview
8.2 Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Immersion Vaccine
- 8.3.1 Overview
- 8.3.2 Immersion Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Injection Vaccine
- 8.4.1 Overview
- 8.4.2 Injection Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Oral Vaccine
- 8.5.1 Overview
- 8.5.2 Oral Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

9. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Species.

9.1 Overview
9.2 Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
9.3 Turbot
- 9.3.1 Turbot: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.4 European Anchovy and Seabass
- 9.4.1 European Anchovy and Seabass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Salmon
- 9.5.1 Salmon: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Mediterranean Sea Bass
- 9.6.1 Mediterranean Sea Bass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Common Dentex and Common Pandora
- 9.7.1 Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Sea Bream
- 9.8.1 Sea Bream: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Rainbow Wrasse
- 9.9.1 Rainbow Wrasse: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.10 Sparus aurata
- 9.10.1 Sparus aurata: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.11 Trout
- 9.11.1 Trout: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.12 Mediterranean Swordfish and Bluefin Tuna
- 9.12.1 Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.13 Grouper and Amberjack
- 9.13.1 Grouper and Amberjack: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.14 Others
- 9.14.1 Others: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

10. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Clinical Indication

10.1 Overview
10.2 Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
10.3 Bacterial Infection
- 10.3.1 Overview
- 10.3.2 Bacterial Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Viral Infection
- 10.4.1 Overview
- 10.4.2 Viral Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

11. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - Geographic Analysis

11.1 Mediterranean Fish Vaccine Market, Revenue and Forecast to 2030
- 11.1.1 Overview
- 11.1.2 Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
  - 11.1.2.1 Mediterranean Fish Vaccine Market, by Vaccine Type
  - 11.1.2.2 Mediterranean Fish Vaccine Market, by Route of Administration
  - 11.1.2.3 Mediterranean Fish Vaccine Market, by Species
  - 11.1.2.4 Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.4.1 Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.4.2 Mediterranean Fish Vaccine Market, by Bacterial Infection
  - 11.1.2.5 Mediterranean Fish Vaccine Market by Country
    - 11.1.2.5.1 France
    - 11.1.2.5.1.1 Overview
    - 11.1.2.5.1.2 France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.1.2.1 France: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.1.2.2 France: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.1.2.3 France: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.1.2.4 France: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.1.2.4.1 France: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.1.2.4.2 France: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.2 Italy
    - 11.1.2.5.2.1 Overview
    - 11.1.2.5.2.2 Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.2.2.1 Italy: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.2.2.2 Italy: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.2.2.3 Italy: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.2.2.4 Italy: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.2.2.4.1 Italy: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.2.2.4.2 Italy: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.3 Spain
    - 11.1.2.5.3.1 Overview
    - 11.1.2.5.3.2 Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.3.2.1 Spain: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.3.2.2 Spain: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.3.2.3 Spain: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.3.2.4 Spain: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.3.2.4.1 Spain: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.3.2.4.2 Spain: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.4 Egypt
    - 11.1.2.5.4.1 Overview
    - 11.1.2.5.4.2 Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.4.2.1 Egypt: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.4.2.2 Egypt: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.4.2.3 Egypt: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.4.2.4 Egypt: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.4.2.4.1 Egypt: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.4.2.4.2 Egypt: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.5 Israel
    - 11.1.2.5.5.1 Overview
    - 11.1.2.5.5.2 Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.5.2.1 Israel: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.5.2.2 Israel: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.5.2.3 Israel: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.5.2.4 Israel: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.5.2.4.1 Israel: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.5.2.4.2 Israel: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.6 Turkey
    - 11.1.2.5.6.1 Overview
    - 11.1.2.5.6.2 Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.6.2.1 Turkey: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.6.2.2 Turkey: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.6.2.3 Turkey: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.6.2.4 Turkey: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.6.2.4.1 Turkey: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.6.2.4.2 Turkey: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.7 Greece
    - 11.1.2.5.7.1 Overview
    - 11.1.2.5.7.2 Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.7.2.1 Greece: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.7.2.2 Greece: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.7.2.3 Greece: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.7.2.4 Greece: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.7.2.4.1 Greece: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.7.2.4.2 Greece: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.8 Rest of the Mediterranean
    - 11.1.2.5.8.1 Overview
    - 11.1.2.5.8.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.8.2.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.8.2.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.8.2.3 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.8.2.4 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.8.2.4.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.8.2.4.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Viral Infection

12. Pre and Post COVID-19 Impact

12.1 Pre and Post COVID-19 Impact

13. Mediterranean Fist Vaccine Market - Industry Landscape

13.1 Overview
13.2 Growth Strategies in Mediterranean Fish Vaccine Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Zoetis Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Merck & Co Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 HIPRA SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 ICTYODEV SAS
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 ACUIPHARMA AQUACULTURE HEALTH SL
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Phibro Animal Health Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Vaxxinova International BV
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Kyoto Biken Laboratories Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Elanco Animal Health Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Ceva SA
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Mediterranean Fish Vaccine Market Segmentation
Table 2. Species of Fishes, Disease and Available Vaccine -
Table 3. Bacterial Pathogens of Fishes -
Table 4. USDA Approved Bacterial Fish Vaccines -
Table 5. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 6. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Species
Table 8. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Clinical Indication
Table 9. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Bacterial Infection
Table 10. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Viral Infection
Table 11. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 12. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 13. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 14. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 15. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 16. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 17. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 18. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 19. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 20. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 21. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 22. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 23. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 24. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 25. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 26. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 27. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 28. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 29. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 30. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 31. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 32. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 33. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 34. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 35. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 36. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 37. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 38. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 39. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 42. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 43. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 44. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 45. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 46. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 47. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 48. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 49. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 50. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 51. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 52. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 53. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 54. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 55. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) -Species
Table 56. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) -Clinical Indication
Table 57. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 58. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 59. Recent Inorganic Growth Strategies in the Mediterranean Fish Vaccine Market
Table 60. Recent Organic Growth Strategies in Mediterranean fish vaccine Market
Table 61. Glossary of Terms

List Of Figures

Figure 1. Mediterranean Fish Vaccine Market Segmentation, By Region
Figure 2. Mediterranean Region: PEST Analysis
Figure 3. Mediterranean Fish Vaccine Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Mediterranean Fish Vaccine Market - Revenue Forecast and Analysis - 2020-2030
Figure 6. Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
Figure 7. Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Live Attenuated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Subunit Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Conjugate Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 14. Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Injection Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
Figure 18. Turbot: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. European Anchovy and Seabass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Salmon: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mediterranean Sea Bass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Sea Bream: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rainbow Wrasse: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Sparus aurata: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Trout: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Grouper and Amberjack: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
Figure 31. Bacterial Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Viral Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Mediterranean Fish Vaccine Market, By Region, 2022 ($Mn)
Figure 34. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Mediterranean Fish Vaccine Market, By Key Countries, 2022 And 2030 (%)
Figure 36. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. Pre and Post COVID-19 Impact on Mediterranean Fish Vaccine Market
Figure 45. Growth Strategies in Mediterranean Fish Vaccine Market